Aurinia Pharmaceuticals Inc (AUPH NASDAQ) stock market data APIs
$15.168
0.84(5.5%)
as of July 20, 2026
Try our APIs with
free plan!
Aurinia Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Prev. Close
15.168
Open
16.0094
High
16.218
Low
15.1273
52 wk Range
8.8-19.25
Market Cap
1 961 M
P/E Ratio
7.0602
Shares Outstanding
129 M
Revenue
298 M
EPS
0.25
Beta
1.415
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Aurinia Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aurinia Pharmaceuticals Inc data using free add-ons & libraries
Get Aurinia Pharmaceuticals Inc Fundamental Data
Aurinia Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 298 M
- EBITDA: 154 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Aurinia Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-04-30
- EPS/Forecast: 0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aurinia Pharmaceuticals Inc News
New
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
Is AUPH a good stock to buy? We came across a bullish thesis on Aurinia Pharmaceuticals Inc. on BioEquity Watch's Substack. In this article, we will summarize the bulls' thesis on AUPH. Aurinia Pharma...
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
Aurinia Pharmaceuticals (AUPH) shares ended the last trading session 6.5% higher at $17.53. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the sess...
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Astellas Pharma Inc. (ALPMY) is a stock that can certainly grab the attention of man...
Aurinia Pharmaceuticals and Four More Stocks See Activist Action
Activists also report to the SEC on Victoria’s Secret, Dell Technologies, Valaris, and Universal Technical Institute. Continue Reading
Get Aurinia Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
